StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 26 Jan 2024 05:48:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/Press+Releases/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html for the full story. http://www.streetinsider.com/PRNewswire/Inside+information+made+public%3A+Nanoform+Announces+Important+Milestone+with+Promising+Clinical+Results+for+Patient-Centric+Nanotechnology-Enhanced+Enzalutamide/22677595.html Fri, 26 Jan 2024 05:48:00 -0500 A.23354209 A.29328024 NANOFH NANOFS O.00231478 O.03261807 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html for the full story. http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Fri, 05 Jan 2024 01:24:00 -0500 A.29328024 NANOFH NANOFS O.03261807 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html for the full story. http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Fri, 05 Jan 2024 01:24:00 -0500 A.29328024 NANOFH NANOFS O.03261807 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html for the full story. http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Fri, 05 Jan 2024 01:24:00 -0500 A.29328024 NANOFH NANOFS O.03261807 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html for the full story. http://www.streetinsider.com/Press+Releases/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Fri, 05 Jan 2024 01:24:00 -0500 A.29328024 NANOFH NANOFS O.03261807 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html for the full story. http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Fri, 05 Jan 2024 01:24:00 -0500 A.29328024 NANOFH NANOFS O.03261807 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html for the full story. http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Fri, 05 Jan 2024 01:24:00 -0500 A.29328024 NANOFH NANOFS O.03261807 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html for the full story. http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Fri, 05 Jan 2024 01:24:00 -0500 A.29328024 NANOFH NANOFS O.03261807 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html for the full story. http://www.streetinsider.com/PRNewswire/Nanoform+Commenced+Relative+Bioavailability+Study+of+Nanotechnology-Enhanced+Enzalutamide/22598624.html Fri, 05 Jan 2024 01:24:00 -0500 A.29328024 NANOFH NANOFS O.03261807 Nanoform grant Global STARMAP® AI License to AstraZeneca http://www.streetinsider.com/Press+Releases/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html for the full story. http://www.streetinsider.com/Press+Releases/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html Mon, 23 Oct 2023 01:30:00 -0500 NANOFH NANOFS Nanoform grant Global STARMAP® AI License to AstraZeneca http://www.streetinsider.com/Press+Releases/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html for the full story. http://www.streetinsider.com/Press+Releases/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html Mon, 23 Oct 2023 01:30:00 -0500 NANOFH NANOFS Nanoform grant Global STARMAP® AI License to AstraZeneca http://www.streetinsider.com/PRNewswire/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html for the full story. http://www.streetinsider.com/PRNewswire/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html Mon, 23 Oct 2023 01:30:00 -0500 NANOFH NANOFS Nanoform grant Global STARMAP® AI License to AstraZeneca http://www.streetinsider.com/PRNewswire/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html for the full story. http://www.streetinsider.com/PRNewswire/Nanoform+grant+Global+STARMAP%C2%AE+AI+License+to+AstraZeneca/22297323.html Mon, 23 Oct 2023 01:30:00 -0500 NANOFH NANOFS Nanoform and Pharmanovia to breathe new life into iconic medicines http://www.streetinsider.com/Press+Releases/Nanoform+and+Pharmanovia+to+breathe+new+life+into+iconic+medicines/20323859.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Nanoform+and+Pharmanovia+to+breathe+new+life+into+iconic+medicines/20323859.html for the full story. http://www.streetinsider.com/Press+Releases/Nanoform+and+Pharmanovia+to+breathe+new+life+into+iconic+medicines/20323859.html Thu, 14 Jul 2022 01:43:00 -0500 NANOFH NANOFS